Editorial policy
How we source and review information
People looking into Phase 1 cancer trials need information that is accurate, current and easy to check. That is what you should find here. Below, we explain where our information comes from and which rules a page must pass before we publish it.
Where our information comes from
The general explanations of clinical research on this website rest on U.S. government sources. Health agencies and research institutes within the government publish this material, and three of the bodies we draw on are the Food and Drug Administration, the National Institutes of Health and the Office for Human Research Protections. If you are reading about Phase 1 cancer trials for yourself or for someone you care for, you can see where each general point began.
The source list for a page sits at its foot. A link earns a place on that list in one way: we open the source ourselves and check what it says. After that, the links are checked again on a regular schedule.
How study listings are produced
Every study listing on this website, and every count shown beside one, is taken from ClinicalTrials.gov. The U.S. National Library of Medicine runs that registry, and it is open to the public. Part of each record appears here word for word as it was registered. We leave the wording alone.
You will find one kind of study here. All of them are in Phase 1, a group that takes in early Phase 1 and combined Phase 1/2. We do not choose which studies belong in it. The registry's own coding of each study settles that.
A processing date is shown on every listing. It tells you when the data were handled, so you can judge their age for yourself. No source is ever more current than the study's own registry record, and you can reach that record through the link in each listing. Phase 1 Cancer Trials does not run any of the studies listed here. We have no affiliation with their sponsors.
Rules every page must pass
- A study exists to find out whether an investigational product is safe and whether it works. We never state or hint that either question has already been answered.
- We make no promise of personal benefit from joining a study, and no promise about your eligibility.
- Payment never opens our copy. Amounts are not published on our pages.
- We put no time pressure on anyone who is weighing a decision.
- Our pages do not offer medical advice.
Each of these rules comes from U.S. Food and Drug Administration guidance on how study participants are recruited. Before any page goes live, software tests it against every rule. A page that fails one stays unpublished.
How pages are written
We use AI writing tools when drafting this website's pages. The tools work from the sources named on the page being drafted. Once a draft exists, it goes through software that compares it with the rules set out above, and this happens for every draft.
Corrections
We want to hear about anything on this website that looks wrong or out of date, so please tell us. Each report is compared with the original source, and if the page is wrong we correct it.
Who is responsible
Phase 1 Cancer Trials is run by Pioneer Research Group. You can read more about us.
Sources and further reading
- Recruiting Study Subjects — Guidance for Institutional Review Boards and Clinical Investigators — U.S. Food and Drug Administration
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections